{"id":"W2786647130","doi":"10.1200/jco.2016.34.15_suppl.tps5090","title":"Randomised phase 3 trial of enzalutamide in first-line androgen deprivation therapy for metastatic prostate cancer: The ANZUP ENZAMET Trial (ANZUP 1304).","year":2016,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Enzalutamide; Prostate cancer; Docetaxel; Androgen deprivation therapy; Oncology; Internal medicine; Hazard ratio; Clinical endpoint; Cancer; Clinical trial; Androgen receptor; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001816903,0.001384572,0.00231313,0.0002971919,0.0003165365,0.000966471,0.000844298,0.001303545,0.0087497],"category_scores_gemma":[0.001770549,0.0004649143,0.002040166,0.0003325497,0.0006570707,0.0008118253,0.0005066637,0.00235859,0.0009219943],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001282057,"about_ca_system_score_gemma":0.00150642,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003682497,"about_ca_topic_score_gemma":0.01202715,"domain_scores_codex":[0.9992406,0.0005027025,0.00002757138,0.00009634395,0.00005685833,0.0000760467],"domain_scores_gemma":[0.9994692,0.0001250192,0.0001528945,0.00004553779,0.00005172252,0.0001557083],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9787281,0.001748076,0.0007678308,0.0009277038,0.001391382,0.00004023262,0.00004159982,0.0004442709,0.001444584,0.0001517169,0.001810225,0.01250436],"study_design_scores_gemma":[0.9648061,0.02844808,0.003403032,0.0000766802,0.0007802905,0.00005354454,0.00002169314,0.0002930929,0.0001475311,0.0003167468,0.001637961,0.00001527637],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9576444,0.01433228,0.0008708368,0.001838012,0.0008994464,0.01088089,0.005722948,0.000234442,0.007576666],"genre_scores_gemma":[0.9636887,0.004561803,0.00314809,0.00298403,0.000409687,0.01017074,0.005635176,0.00005084839,0.009350819],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0087497,"threshold_uncertainty_score":0.02927065,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2290558006825888,"score_gpt":0.5371807235506563,"score_spread":0.3081249228680675,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}